A multicenter, retrospective archive study of radiological and clinical features of ALK-positive non-small cell lung cancer patients and crizotinib efficacy.

Autor: Kilickap S; Department of Preventive Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.; Department of Medical Oncology, Istinye University Faculty of Medicine, Istanbul, Turkey.; Ankara Liv Hospital, Medical Oncology, Ankara, Turkey., Ozturk A; Department of Medical Oncology, Sureyyapasa Chest Diseases and Chest Surgery Training and Research Hospital, Istanbul, Turkey., Karadurmus N; Department of Medical Oncology, University of Health Sciences Gulhane Training and Research Hospital, Ankara, Turkey., Korkmaz T; Department of Medical Oncology, Acibadem University, School of Medicine, Istanbul, Turkey., Yumuk PF; Division of Medical Oncology, Marmara University School of Medicine, Istanbul, Turkey.; Medical Oncology Division, Koc University, School of Medicine, Istanbul, Turkey., Cicin I; Department of Medical Oncology, Trakya University Medical Faculty, Edirne, Turkey.; Istinye University Medical Center, Istanbul, Turkey., Paydas S; Department of Internal Diseases, Cukurova University Faculty of Medicine, Adana, Turkey., Cilbir E; Department of Medical Oncology, University of Health Sciences Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey., Sakalar T; Erciyes University, Faculty of Medicine, Kayseri, Turkey., Uysal M; Department of Medical Oncology, Afyon Kocatepe University Faculty of Medicine, Afyon, Turkey.; Medstar Antalya Hospital, Medical Oncology Cancer Center, Antalya, Turkey.; Antalya Bilim University, Institute of Health Sciences, Antalya, Turkey., Yesil Cinkir H; Department of Internal Diseases, Gaziantep University Faculty of Medicine, Division of Medical Oncology, Gaziantep, Turkey., Uskent N; Department of Medical Oncology, Anadolu Medical Center, Kocaeli, Turkey., Demir N; Sivas Numune Training and Research Hospital, Medical Oncology, Sivas, Turkey.; Acibadem Health Group, Kayseri Hospital, Unit of Medical Oncology, Kayseri, Turkey., Sakin A; Department of Medical Oncology, Istanbul Prof. Dr. Cemil Tascioglu City Hospital (University of Health Sciences Okmeydani Training and Research Hospital), Istanbul, Turkey.; Division of Medical Oncology, Medipol University, Medipol Bahcelievler Hospital, Istanbul, Turkey., Dursun OU; Pfizer Oncology, Pfizer, Turkey., Aver B; Pfizer Oncology, Pfizer, Turkey., Turhal NS; Department of Medical Oncology, Anadolu Medical Center, Kocaeli, Turkey., Keskin S; Department of Oncology, Memorial Sisli Hospital, Istanbul, Turkey., Tural D; Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Clinic of Medical Oncology, Istanbul, Turkey., Eralp Y; Department of Medical Oncology, Gayrettepe Florence Nightingale Hospital, Istanbul, Turkey.; Acibadem Mehmet Ali Aydinlar University, Institute of Senology, Istanbul, Turkey.; Acibadem Healthcare Group, Maslak Hospital, Unit of Medical Oncology, Istanbul, Turkey., Bugdayci Basal F; Department of Medical Oncology, Ankara Ataturk Chest Diseases and Chest Surgery Training and Research Hospital, Ankara, Turkey.; Department of Medical Oncology, Lösante Children's and Adult Hospital, Ankara, Turkey., Yasar HA; Department of Medical Oncology, Lösante Children's and Adult Hospital, Ankara, Turkey.; Department of Medical Oncology, Ankara University, Faculty of Medicine, Ankara, Turkey., Sendur MAN; Ankara Atatürk Training and Research Hospital, Clinic of Medical Oncology, Ankara, Turkey.; Department of Internal Medicine, Medical Oncology Division, Ankara Yildirim Beyazit University, Ankara City Hospital, Ankara, Turkey., Demirci U; Department of Medical Oncology, Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Turkey.; Department of Medical Oncology, Memorial Hospital, Ankara, Turkey.; Department of Internal Medicine and Medical Oncology, Medical Sciences Division, Uskudar University, Faculty of Medicine, Istanbul, Turkey., Cubukcu E; Department of Internal Diseases, Medical Oncology, Bursa Uludag University, Faculty of Medicine, Bursa, Turkey.; Medicana Health Group-Bursa Hospital, Medical Oncology, Bursa, Turkey., Karaagac M; Department of Internal Diseases, Division of Medical Oncology, Necmettin Erbakan University, Meram Medical Faculty, Konya, Turkey., Cakar B; Department of Internal Diseases, Ege University Faculty of Medicine Tulay Aktas Oncology Hospital, Izmir, Turkey., Tatli AM; Department of Internal Diseases, Division of Medical Oncology, Akdeniz University, Faculty of Medicine, Antalya, Turkey., Yetisyigit T; Department of Medical Oncology, Tekirdag Namik Kemal University, Faculty of Medicine, Tekirdag, Turkey.; Department of Medical Oncology, King Hamad University Hospital, Bahrain Oncology Center, Manama, Kingdom of Bahrain., Urvay S; Department of Internal Diseases, Kayseri Acibadem Hospital, Medical Oncology, Kayseri, Turkey., Gursoy P; Department of Medical Oncology, University of Health Sciences Dr. Suat Seren Chest Diseases and Chest Surgery Training and Research Hospital, Izmir, Turkey.; Department of Internal Diseases, Medical Oncology Division, Ege University, Faculty of Medicine, Izmir, Turkey., Oyan B; Department of Medical Oncology, Acibadem University, School of Medicine, Istanbul, Turkey., Turna ZH; Department of Internal Diseases, Division of Medical Oncology, Istanbul University Cerrahpasa, Faculty of Medicine, Istanbul, Turkey., Isikdogan A; Department of Medical Oncology, Dicle University, Faculty of Medicine, Diyarbakir, Turkey., Olmez OF; Department of Medical Oncology, Medipol University, Faculty of Medicine, Istanbul, Turkey., Yazici O; University of Health Sciences, Ankara Numune Training and Research Hospital, Clinic of Medical Oncology, Ankara, Turkey.; Department of Internal Diseases, Medical Oncology Division, Gazi University, Faculty of Medicine, Ankara, Turkey., Cabuk D; Department of Internal Diseases, Medical Oncology, Kocaeli University Faculty of Medicine, Kocaeli, Istanbul, Turkey., Seker MM; Department of Medical Oncology, Bayindir Hospital Sogutozu, Ankara, Turkey.; Department of Medical Oncology, Koru Health Group, Ankara, Turkey., Unal OU; Department of Medical Oncology, Izmir Bozyaka Training and Research Hospital, Izmir, Turkey.; Department of Medical Oncology-Chemotherapy, University of Health Sciences, Izmir Tepecik Training and Research Hospital, Izmir, Turkey., Meydan N; Department of Medical Oncology, Adnan Menderes University, Faculty of Medicine, Aydin, Turkey.; Department of Medical Oncology, Medicana Health Group, Istanbul, Turkey., Okutur SK; Department of Medical Oncology, Medical Park Bahcelievler Hospital, Istanbul, Turkey.; Department of Medical Oncology, Memorial Hospital, Istanbul, Turkey.; Department of Medical Oncology, Istanbul Arel University, Istanbul, Turkey., Tunali D; Department of Medical Oncology, Koc University, Faculty of Medicine, Istanbul, Turkey., Erman M; Departments of Preventive and Medical Oncology, Hacettepe University, Cancer Institute, Ankara, Turkey.

Publikováno v: Medicine [Medicine (Baltimore)] 2024 May 24; Vol. 103 (21), pp. e37972.

Treatment outcomes and prognostic factors in patients with driver mutant non-small cell lung cancer and de novo brain metastases.

Autor: Kahraman S; Department of Medical Oncology, Ankara Bilkent City Hospital, Ankara Yildirim Beyazit University, 06800, Ankara, Turkey. sedakayacan.kahraman@gmail.com., Karakaya S; Department of Medical Oncology, Ankara Ataturk Sanatoryum Training and Research Hospital, Ankara, Turkey., Kaplan MA; Department of Medical Oncology, Dicle University Medical Faculty Hospital, Diyarbakir, Turkey., Goksu SS; Department of Medical Oncology, Akdeniz University Hospital, Antalya, Turkey., Ozturk A; Department of Medical Oncology, Sureyyapasa Chest Diseases and Chest Surgery Training and Research Hospital, Istanbul, Turkey., Isleyen ZS; Department of Medical Oncology, Faculty of Medicine Hospital, Bezmialem Vakif University, Istanbul, Turkey., Hamdard J; Department of Medical Oncology, Medipol University Hospital, Istanbul, Turkey., Yildirim S; Department of Medical Oncology, Kartal Dr. Lutfi Kirdar City Hospital, Istanbul, Turkey., Dogan T; Department of Medical Oncology, Pamukkale University Medical Faculty Hospital, Denizli, Turkey., Isik S; Department of Medical Oncology, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey., Celebi A; Department of Medical Oncology, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey., Gulbagci BB; Department of Medical Oncology, Sakarya University School of Medicine, Sakarya, Turkey., Paksoy N; Department of Medical Oncology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey., Dogan M; Department of Medical Oncology, Ankara Dr Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey., Turk HM; Department of Medical Oncology, Faculty of Medicine Hospital, Bezmialem Vakif University, Istanbul, Turkey., Bilici A; Department of Medical Oncology, Medipol University Hospital, Istanbul, Turkey., Tatli AM; Department of Medical Oncology, Akdeniz University Hospital, Antalya, Turkey., Akbas S; Department of Medical Oncology, Koç University Medical Faculty Hospital, Istanbul, Turkey., Turan N; Department of Medical Oncology, Kartal Dr. Lutfi Kirdar City Hospital, Istanbul, Turkey., Hacibekiroglu I; Department of Medical Oncology, Sakarya University School of Medicine, Sakarya, Turkey., Dogu GG; Department of Medical Oncology, Pamukkale University Medical Faculty Hospital, Denizli, Turkey., Aydiner A; Department of Medical Oncology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey., Sumbul AT; Department of Medical Oncology, Baskent University Adana Dr. Turgut Noyan Application and Research Center, Adana, Turkey., Akyurek S; Department of Radiation Oncology, Faculty of Medicine, Ankara University, Ankara, Turkey., Yalciner M; Department of Medical Oncology, Faculty of Medicine, Ankara University, Ankara, Turkey., Demirkazik A; Department of Medical Oncology, Faculty of Medicine, Ankara University, Ankara, Turkey., Gursoy P; Department of Medical Oncology, Ege University Medical Faculty Hospital, Izmir, Turkey., Aykan MB; Department of Medical Oncology, Gulhane Training and Research Hospital, Ankara, Turkey., Sahin E; Department of Medical Oncology, Kocaeli University Medical Faculty Hospital, Kocaeli, Turkey., Karadag İ; Department of Medical Oncology, Hittite University Corum Training and Research Hospital, Corum, Turkey., Kostek O; Department of Medical Oncology, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey., Er MM; Department Of Medical Oncology, Necmettin Erbakan University Meram Medical Faculty Hospital, Konya, Turkey., Artaç M; Department Of Medical Oncology, Necmettin Erbakan University Meram Medical Faculty Hospital, Konya, Turkey., Duzkopru Y; Department of Medical Oncology, Ankara Etlik City Hospital, Ankara, Turkey., Aydin D; Department of Medical Oncology, Kocaeli Derince Training and Research Hospital, Kocaeli, Turkey., Isik D; Department of Medical Oncology, Kocaeli Medical Park Hospital, Kocaeli, Turkey., Karakas Y; Department of Medical Oncology, Acıbadem Bodrum Hospital, Mugla, Turkey., Kilickap S; Department of Medical Oncology, Liv Hospital, Istinye University, Ankara, Turkey., Erol C; Department of Medical Oncology, Ankara Bilkent City Hospital, Ankara Yildirim Beyazit University, 06800, Ankara, Turkey., Demir B; Department of Medical Oncology, Aydin Ataturk State Hospital, Aydin, Turkey., Civelek B; Department of Medical Oncology, Ankara Bilkent City Hospital, Ankara, Turkey., Ergun Y; Department of Medical Oncology, Batman Training and Research Hospital, Batman, Turkey., Akinci MB; Department of Medical Oncology, Ankara Bilkent City Hospital, Ankara Yildirim Beyazit University, 06800, Ankara, Turkey., Dogan I; Department of Medical Oncology, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey., Karadurmus N; Department of Medical Oncology, Gulhane Training and Research Hospital, Ankara, Turkey., Yumuk PF; Department of Medical Oncology, Koç University Medical Faculty Hospital, Istanbul, Turkey., Sendur MAN; Department of Medical Oncology, Ankara Bilkent City Hospital, Ankara Yildirim Beyazit University, 06800, Ankara, Turkey.

Publikováno v: Scientific reports [Sci Rep] 2024 Mar 09; Vol. 14 (1), pp. 5820. Date of Electronic Publication: 2024 Mar 09.

Tailoring adjuvant chemotherapy by circulating tumor DNA (ctDNA) in older patients with stage II-III colon cancer.

Autor: Akagündüz B; Department of Medical Oncology, Erzincan Binali Yıldrıım University Medical School, Erzincan, Turkey. Electronic address: drbaran04@hotmail.com., Guven DC; Department of Medical Oncology, Hacettepe University Medical School, Istanbul, Turkey., Ozer M; Department of Internal Medicine, Capital Health Regional Medical Center, Trenton, NJ, USA. Electronic address: Mozer@capitalhealth.org., Okten IN; Department of Medical Oncology, Gaziantep Ersin Arslan State Hospital, Gaziantep, Turkey., Atag E; Department of Medical Oncology, Haydarpaşa Numune Research Hospital, Istanbul, Turkey., Unek İT; Department of Medical Oncology, Dokuzeylül University Medical School, 34000 Istanbul, Turkey., Tatli AM; Department of Medical Oncology, Akdeniz University Medical School, 07010 Antalya, Turkey., Karaoglu A; Department of Medical Oncology, Dokuzeylül University Medical School, 34000 Istanbul, Turkey.

Publikováno v: Journal of geriatric oncology [J Geriatr Oncol] 2023 Mar; Vol. 14 (2), pp. 101367. Date of Electronic Publication: 2022 Aug 26.

Comparison of the Efficacy and Safety of 3 Months of CAPOX Followed by 3 Months of Capecitabine and 6 Months of CAPOX/FOLFOX in the Adjuvant Treatment of Low-Risk Stage III Colon Cancer Treated Surgically.

Autor: Bardakci M; Department of Medical Oncology, Ankara City Hospital, Ankara, Turkey., Demirtas Esmer D; Department of Medical Oncology, Ankara City Hospital, Ankara, Turkey., Hafizoglu E; Department of Medical Oncology, Ankara City Hospital, Ankara, Turkey., Yaslikaya S; Department of Medical Oncology, Cukurova University Faculty of Medicine, Adana, Turkey., Genc TB; Department of Medical Oncology, Akdeniz University Faculty of Medicine, Antalya, Turkey., Ozcelik M; Department of Medical Oncology, Umraniye Training and Research Hospital, Istanbul, Turkey., Erdat EC; Department of Medical Oncology, Ankara University Faculty of Medicine, Ankara, Turkey., Hendem E; Department of Medical Oncology, Necmettin Erbakan University Meram Faculty of Medicine, Konya, Turkey., Buyukbayram ME; Department of Medical Oncology, Ataturk University Faculty of Medicine, Erzurum, Turkey., Alaca Topcu Z; Department of Medical Oncology, Medeniyet University Faculty of Medicine, Istanbul, Turkey., Kalkan Z; Department of Medical Oncology, Dicle University Faculty of Medicine, Diyarbakir, Turkey., Yildirim N; Department of Medical Oncology, Firat University Faculty of Medicine, Elazig, Turkey., Celebi A; Department of Medical Oncology, Marmara University Faculty of Medicine, Istanbul, Turkey., Ergun Y; Department of Medical Oncology, Batman World Hospital, Batman, Turkey., Paydas S; Department of Medical Oncology, Cukurova University Faculty of Medicine, Adana, Turkey., Tatli AM; Department of Medical Oncology, Akdeniz University Faculty of Medicine, Antalya, Turkey., Karakas H; Department of Medical Oncology, Ankara City Hospital, Ankara, Turkey., Koseci T; Department of Medical Oncology, Cukurova University Faculty of Medicine, Adana, Turkey., Sendur MAN; Department of Medical Oncology, Ankara City Hospital, Ankara, Turkey.

Publikováno v: Oncology [Oncology] 2023; Vol. 101 (11), pp. 723-729. Date of Electronic Publication: 2023 Jun 28.

Cisplatin plus paclitaxel and bevacizumab versus carboplatin plus paclitaxel and bevacizumab for the first-line treatment of metastatic or recurrent cervical cancer.

Autor: Ilhan Y; Department of Medical Oncology, Akdeniz University, Antalya, Turkey dryusufilhan@gmail.com., Tatli AM; Department of Medical Oncology, Akdeniz University, Antalya, Turkey., Teker F; Department of Medical Oncology, Gaziantep University, Gaziantep, Turkey., Onder AH; Department of Medical Oncology, Antalya Training and Research Hospital, Antalya, Turkey., Kose F; Department of Medical Oncology, Başkent Üniversitesi Adana Uygulama ve Araştırma Merkezi, Adana, Turkey., Geredeli C; Department of Medical Oncology, Okmeydani Training and Research Hospital, Istanbul, Turkey., Karaagac M; Department of Clinical Oncology, Necmettin Erbakan University Meram Faculty of Medicine, Konya, Turkey., Kaplan MA; Department of Medical Oncology, Dicle University, Diyarbakir, Turkey., Inanc M; Department of Medical Oncology, Erciyes University, Kayseri, Turkey., Goktas Aydin S; Department of Medical Oncology, Istanbul Medipol University, Istanbul, Turkey., Kargi A; Department of Medical Oncology, Medstar Antalya Hospital, Antalya, Turkey., Arak H; Department of Medical Oncology, Gaziantep University, Gaziantep, Turkey., Ozturk B; Department of Medical Oncology, Antalya Training and Research Hospital, Antalya, Turkey., Besen AA; Department of Medical Oncology, Başkent Üniversitesi Adana Uygulama ve Araştırma Merkezi, Adana, Turkey., Selvi O; Department of Medical Oncology, Okmeydani Training and Research Hospital, Istanbul, Turkey., Korkmaz M; Department of Clinical Oncology, Necmettin Erbakan University Meram Faculty of Medicine, Konya, Turkey., Oruc Z; Department of Medical Oncology, Dicle University, Diyarbakir, Turkey., Bozkurt O; Department of Medical Oncology, Erciyes University, Kayseri, Turkey., Bilici A; Department of Medical Oncology, Istanbul Medipol University, Istanbul, Turkey., Bayram S; Department of Medical Oncology, Antalya Training and Research Hospital, Antalya, Turkey., Dae SA; Department of Medical Oncology, Başkent Üniversitesi Adana Uygulama ve Araştırma Merkezi, Adana, Turkey., Ozdogan M; Department of Medical Oncology, Medstar Antalya Hospital, Antalya, Turkey., Coskun HS; Department of Medical Oncology, Akdeniz University, Antalya, Turkey., Sezgin Goksu S; Department of Medical Oncology, Akdeniz University, Antalya, Turkey.

Publikováno v: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2022 Apr 04; Vol. 32 (4), pp. 502-507. Date of Electronic Publication: 2022 Apr 04.